vivo anti mouse cd8a Search Results


mouse cd8a  (Cytek Biosciences)
93
Cytek Biosciences mouse cd8a
In vivo immune responses activated by AuNP@HMV@SPs. (a) Schematic illustration of experimental design to evaluate the in vivo immune responses activated by AuNP@HMV@SPs (OMVs: 2 µg/mL, SP: 1.5 µg/mL) via subcutaneous injection. (b) Percentage of CD80 + and CD86 + cells (gated on CD11c + cells) in the lymph nodes collected on day 21 ( n = 4). (c) Percentage of GL7 + cells (gated on CD19 + IgG − cells) in the spleen collected on day 21 ( n = 5). (d) Anti‐ P. aeruginosa specific antibody IgG titers in serum collected on day 21 ( n = 5). (e) CD3 + T cells, (f) CD3 + CD4 + T cells, and (g) CD3 + <t>CD8</t> + T cells in the spleen collected on day 21 ( n = 5). Naive mice without immunization were used as control. Statistical analysis was conducted using the student's t ‐test or One‐way ANOVA with Tukey's post hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001 and ns representing non‐significance.
Mouse Cd8a, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vivo+anti+mouse+cd8a/In+Vivo+Ready+Anti-Mouse+CD8a/pmc11472236-33-13-25
Average 93 stars, based on 1 article reviews
mouse cd8a - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
in vivo ready anti mouse cd8a  (Tonbo Biosciences)
N/A
In Vivo Ready Anti Mouse CD8a 53 6 7
   Buy from Supplier
in vivo ready anti mouse cd8a 53 6 7 antibody  (Abcepta)
N/A
The 53 6 7 antibody reacts with the 32 34 kDa alpha subunit of mouse CD8 known as CD8a or CD8 alpha CD8a can form a homodimer CD8 alpha alpha but is more commonly expressed
   Buy from Supplier

Image Search Results


In vivo immune responses activated by AuNP@HMV@SPs. (a) Schematic illustration of experimental design to evaluate the in vivo immune responses activated by AuNP@HMV@SPs (OMVs: 2 µg/mL, SP: 1.5 µg/mL) via subcutaneous injection. (b) Percentage of CD80 + and CD86 + cells (gated on CD11c + cells) in the lymph nodes collected on day 21 ( n = 4). (c) Percentage of GL7 + cells (gated on CD19 + IgG − cells) in the spleen collected on day 21 ( n = 5). (d) Anti‐ P. aeruginosa specific antibody IgG titers in serum collected on day 21 ( n = 5). (e) CD3 + T cells, (f) CD3 + CD4 + T cells, and (g) CD3 + CD8 + T cells in the spleen collected on day 21 ( n = 5). Naive mice without immunization were used as control. Statistical analysis was conducted using the student's t ‐test or One‐way ANOVA with Tukey's post hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001 and ns representing non‐significance.

Journal: Journal of Extracellular Vesicles

Article Title: A multiantigenic antibacterial nanovaccine utilizing hybrid membrane vesicles for combating Pseudomonas aeruginosa infections

doi: 10.1002/jev2.12524

Figure Lengend Snippet: In vivo immune responses activated by AuNP@HMV@SPs. (a) Schematic illustration of experimental design to evaluate the in vivo immune responses activated by AuNP@HMV@SPs (OMVs: 2 µg/mL, SP: 1.5 µg/mL) via subcutaneous injection. (b) Percentage of CD80 + and CD86 + cells (gated on CD11c + cells) in the lymph nodes collected on day 21 ( n = 4). (c) Percentage of GL7 + cells (gated on CD19 + IgG − cells) in the spleen collected on day 21 ( n = 5). (d) Anti‐ P. aeruginosa specific antibody IgG titers in serum collected on day 21 ( n = 5). (e) CD3 + T cells, (f) CD3 + CD4 + T cells, and (g) CD3 + CD8 + T cells in the spleen collected on day 21 ( n = 5). Naive mice without immunization were used as control. Statistical analysis was conducted using the student's t ‐test or One‐way ANOVA with Tukey's post hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001 and ns representing non‐significance.

Article Snippet: FITC‐conjugated anti‐mouse CD11c, PE‐conjugated anti‐mouse CD80, APC‐conjugated anti‐mouse CD86, APC‐conjugated anti‐mouse CD3, PE‐conjugated anti‐mouse CD8a, FITC‐conjugated anti‐mouse CD4, and PE‐conjugated anti‐mouse CD19 were purchased from Tonbo Biosciences, U.S.A.. APC‐conjugated anti‐mouse GL‐7 was obtained from Laizee Biotech, Shanghai, China.

Techniques: In Vivo, Injection, Control